UK Innovation Zones

Investor · London and Sheffield

British Patient Capital

Subsidiary of the British Business Bank investing in and alongside venture and growth funds to support UK companies scaling in the UK.

Investment profile

Stage

  • Series A
  • Series B
  • Growth
  • Late stage

Investment type

  • Government-backed
  • Growth capital

Geographic mandate

UK only

Typical cheque size is shown only where the investor publishes it. Where it is absent, it is not published rather than estimated.

Connected ecosystem

Companies in the same place and sectors

  • Google DeepMind

    AI research laboratory founded in London and now the AI research division of an international technology group.

  • Wayve

    Develops embodied AI driving software trained end-to-end rather than through hand-coded rules.

  • Synthesia

    AI video generation platform used for enterprise communication and training content.

  • Quantexa

    Decision intelligence platform used by banks and government for entity resolution and financial crime detection.

  • GSK

    Global biopharma company headquartered in London with UK research and manufacturing operations.

  • BenevolentAI

    Applies machine learning to target identification and drug discovery.

  • Oxford Quantum Circuits

    Superconducting quantum computing company providing quantum computing as a service from UK data centres.

Relevant proposed UKIZ missions

Listing does not imply participation. No investor here is a UKIZ participant unless stated on the UKIZ people page.

Proposed by UKIZ · not a government designation

Sources

  • Organisation's own published material

Last verified: 15 August 2026